Abstract
Acute myeloid leukaemia (AML) is a blood/bone marrow cancer originating from myeloid cell precusors capable of self-renewing. AML cells implement biochemical mechanisms which allow them not only to survive, but also to successfully escape immune surveillance. ln this work, we discuss crucial molecular mechanisms used by human AML cells in order to evade immune attack.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sehgal, A., Whiteside, T. L. & Boyiadzis, M. Programmed death-1 checkpoint blockade in acute myeloid leukemia. Expert. Opin. Biol. Ther. 15, 1191–1203 (2015).
Goncalves Silva, I. et al. The Tim-3-galectin-9 secretory pathway is involved in the immune escape of human acute myeloid leukemia cells. EBioMedicine 22, 44–57 (2017).
Geng, H. et al. Soluble form of T cell Ig mucin 3 is an inhibitory molecule in T cell-mediated immune response. J. Immunol. 176, 1411–1420 (2006).
Karwacz, K. et al. PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+T cells. EMBO Mol. Med. 3, 581–592 (2011).
Kursunel, M. A. & Esendagli, G. A co-inhibitory alliance in myeloid leukemia: TIM-3/Galectin-9 complex as a new target for checkpoint blockade therapy. EBioMedicine 23, 6–7 (2017).
Jin, H. T. et al. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc. Natl. Acad. Sci. USA 107, 14733–14738 (2010).
Kikushige, Y. et al. A TIM-3/Gal-9 autocrine stimulatory loop drives self-renewal of human myeloid leukemia stem cells and leukemic progression. Cell Stem Cell 17, 341–352 (2015).
Prokhorov, A. et al. The immune receptor Tim-3 mediates activation of PI3 kinase/mTOR and HIF-1 pathways in human myeloid leukaemia cells. Int. J. Biochem. Cell Biol. 59, 11–20 (2015).
Goncalves Silva, I., Gibbs, B. F., Bardelli, M., Varani, L. & Sumbayev, V. V. Differential expression and biochemical activity of the immune receptor Tim-3 in healthy and malignant human myeloid cells. Oncotarget 6, 33823–33833 (2015).
Goncalves Silva, I. et al. The immune receptor Tim-3 acts as a trafficker in a Tim-3/galectin-9 autocrine loop in human myeloid leukemia cells. Oncoimmunology 5, e1195535 (2016).
Sumbayev, V. V. et al. Expression of functional neuronal receptor latrophilin 1 in human acute myeloid leukaemia cells. Oncotarget 7, 45575–45583 (2016).
Folgiero, V. et al. TIM-3/Gal-9 interaction induces IFNgamma-dependent IDO1 expression in acute myeloid leukemia blast cells. J. Hematol. Oncol. 8, 36 (2015).
Norde, W. J. et al. PD-1/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation. Cancer Res. 71, 5111–5122 (2011).
Yasinska, I. M. et al. High mobility group box 1 (HMGB1) acts as an “alarmin” to promote acute myeloid leukaemia progression. Oncoimmunology 7, e1438109 (2018).
Wyszynski, R. W., Gibbs, B. F., Varani, L., Iannotta, D. & Sumbayev, V. V. Interleukin-1 beta induces the expression and production of stem cell factor by epithelial cells: crucial involvement of the PI-3K/mTOR pathway and HIF-1 transcription complex. Cell. Mol. Immunol. 13, 47–56 (2016).
Kang, C. W. et al. Apoptosis of tumor infiltrating effector TIM-3+CD8+T cells in colon cancer. Sci. Rep. 5, 15659 (2015).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors have no competing interests to declare.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yasinska, I.M., Gonçalves Silva, I., Sakhnevych, S. et al. Biochemical mechanisms implemented by human acute myeloid leukemia cells to suppress host immune surveillance. Cell Mol Immunol 15, 989–991 (2018). https://doi.org/10.1038/s41423-018-0047-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41423-018-0047-6
Keywords
This article is cited by
-
Galectin-9, a pro-survival factor inducing immunosuppression, leukemic cell transformation and expansion
Molecular Biology Reports (2024)